 "Cipla Q1 net profit dips 40%")
The Mumbai-based Cipla Ltd has posted a net profit of Rs 294.5 crore for the first quarter ended June 30, 2014 as compared to Rs 485.3 crore for the quarter ended June 30, 2013, a decline of 40%. Total income has increased from Rs 2580 crore for the quarter ended June 30, 2013 to Rs 2760.3 crore.
Company's total expenses went up by 17% at Rs 2303 crore for the fist quarter of FY 14-15. Material cost is at 37.7% of income from operations in Q1 FY1415 as compared to 36.6% in Q1 FY1314, company said in a statement.
On Thursday, Cipla shares were closed at Rs 448, up by 1.98% or Rs 8.70 on BSE.
Domestic sales grew by 17% to Rs 1289 crore, up from Rs 1102 crore during Q1 FY13-14, on account of growth in respiratory, anti-infective and cardiac therapies. Exports of formulations grew by 12.7% to Rs 1218 crore, up from Rs 1081 crore, due to growth in anti-retroviral, anti-asthma and anti-allergic segments, company said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app